Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
104.77 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 131.314 | 196.245 | 277.133 | 186.419 | 120.282 | 251.453 | 141.102 | 108.973 | 71.914 | 64.538 | 48.974 | 31.388 | 30.037 | 23.538 | 38.94 | 27.315 | 12.894 | 140.96 | 176.608 | 163.512 | 141.14 | 96.64 | 76.341 | 48.11 | 40.9 | 17.7 | 51.7 | 36.8 | 24.5 | 13.3 |
| Cost of Revenue
| 11.561 | 52.827 | 62.176 | 30.419 | 11.347 | 6.337 | 5.366 | 5.571 | 5.807 | 9.136 | 5.733 | 3.601 | 4.909 | 0 | 15.235 | 0 | 0 | 22.642 | 39.847 | 39.804 | 31.618 | 20.306 | 13.947 | 1.618 | 3.1 | -7.7 | -9.8 | -9.4 | -3.7 | 24.7 |
| Gross Profit
| 119.753 | 143.418 | 214.957 | 156 | 108.935 | 245.116 | 135.736 | 103.402 | 66.107 | 55.402 | 43.241 | 27.787 | 25.128 | 23.538 | 23.705 | 27.315 | 12.894 | 118.318 | 136.761 | 123.708 | 109.522 | 76.334 | 62.394 | 46.492 | 37.8 | 25.4 | 61.5 | 46.2 | 28.2 | -11.4 |
| Gross Profit Ratio
| 0.912 | 0.731 | 0.776 | 0.837 | 0.906 | 0.975 | 0.962 | 0.949 | 0.919 | 0.858 | 0.883 | 0.885 | 0.837 | 1 | 0.609 | 1 | 1 | 0.839 | 0.774 | 0.757 | 0.776 | 0.79 | 0.817 | 0.966 | 0.924 | 1.435 | 1.19 | 1.255 | 1.151 | -0.857 |
| Reseach & Development Expenses
| 24.537 | 36.082 | 69.012 | 59.392 | 55.908 | 27.863 | 26.887 | 21.221 | 13.38 | 12.122 | 9.274 | 10.79 | 10.291 | 22.067 | 39.87 | 30.77 | 44.623 | 41.926 | 56.075 | 65.204 | 67.679 | 58.807 | 51.104 | 51.287 | 59.4 | 70.7 | 72.4 | 59.5 | 41.4 | 0 |
| General & Administrative Expenses
| 52.79 | 70.062 | 57.483 | 64.435 | 41.884 | 37.734 | 28.653 | 26.621 | 24.378 | 22.57 | 17.984 | 16.108 | 14.977 | 29.723 | 30.446 | 23.785 | 30.41 | 248.281 | 107.157 | 95.875 | 61.021 | 41.678 | 34.427 | 34.114 | 27.3 | 16.6 | 10.1 | 10.2 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 52.79 | 70.062 | 57.483 | 64.435 | 41.884 | 37.734 | 28.653 | 26.621 | 24.378 | 22.57 | 17.984 | 16.108 | 14.977 | 29.723 | 15.211 | 23.785 | 30.41 | 248.281 | 107.157 | 95.875 | 61.021 | 41.678 | 34.427 | 34.114 | 27.3 | 16.6 | 10.1 | 10.2 | 8 | 7 |
| Other Expenses
| -32.605 | 34.237 | 9.567 | 23.442 | 16.864 | 15.792 | 12.12 | 10.643 | -10.034 | -3.189 | -2.139 | -2.789 | 0 | 0 | 0 | -1.964 | -1.964 | -3.119 | 78.049 | 62.03 | 50.531 | 16.689 | 0 | 6.973 | 7.4 | 7.7 | 9.8 | 9.4 | 3.7 | 2.5 |
| Operating Expenses
| 109.932 | 140.381 | 136.062 | 147.269 | 114.656 | 81.389 | 67.66 | 58.485 | 37.758 | 34.692 | 27.258 | 26.898 | 25.268 | 51.79 | 70.316 | 52.591 | 73.069 | 287.088 | 163.232 | 161.079 | 128.7 | 100.485 | 85.531 | 92.374 | 94.1 | 95 | 92.3 | 79.1 | 53.1 | 9.5 |
| Operating Income
| 9.821 | -25.503 | 78.895 | 8.55 | -5.721 | 163.727 | 68.076 | 43.885 | 27.329 | 19.626 | 14.943 | 0.574 | -0.698 | -29.304 | -9.967 | -97.276 | -60.175 | -168.77 | -26.471 | -37.371 | -19.178 | -24.151 | -23.137 | -45.882 | -56.3 | -69.6 | -30.8 | -32.9 | -24.9 | -20.9 |
| Operating Income Ratio
| 0.075 | -0.13 | 0.285 | 0.046 | -0.048 | 0.651 | 0.482 | 0.403 | 0.38 | 0.304 | 0.305 | 0.018 | -0.023 | -1.245 | -0.256 | -3.561 | -4.667 | -1.197 | -0.15 | -0.229 | -0.136 | -0.25 | -0.303 | -0.954 | -1.377 | -3.932 | -0.596 | -0.894 | -1.016 | -1.571 |
| Total Other Income Expenses Net
| 53.839 | 61.514 | -31.597 | -19.088 | 802.36 | 43.88 | -10.845 | -36.957 | 6.98 | -9.408 | -6.776 | -4.754 | -0.05 | 11.147 | -0.347 | -72.234 | 0.763 | 4.45 | 11.226 | 15.54 | -6.092 | -3.236 | -8.363 | -0.825 | -5.7 | -43 | -61.3 | 3.7 | -33.8 | -5.5 |
| Income Before Tax
| 63.66 | 36.011 | 47.298 | -10.538 | 796.639 | 173.33 | 57.231 | 7.96 | 35.329 | 11.302 | 9.207 | -3.865 | -2.93 | -15.403 | -9.872 | -97.515 | -53.456 | -174.273 | 36.34 | -44.908 | -37.462 | -32.596 | -31.5 | -46.707 | -62 | -112.6 | -92.1 | -29.2 | -58.7 | -26.4 |
| Income Before Tax Ratio
| 0.485 | 0.184 | 0.171 | -0.057 | 6.623 | 0.689 | 0.406 | 0.073 | 0.491 | 0.175 | 0.188 | -0.123 | -0.098 | -0.654 | -0.254 | -3.57 | -4.146 | -1.236 | 0.206 | -0.275 | -0.265 | -0.337 | -0.413 | -0.971 | -1.516 | -6.362 | -1.781 | -0.793 | -2.396 | -1.985 |
| Income Tax Expense
| 9.841 | 41.23 | -10.288 | -7.553 | 167.337 | 30.009 | 44.675 | 10.327 | -219.596 | 0.41 | 0.374 | -1.191 | -13.103 | -2.617 | -7.924 | -0.055 | -18.697 | -38.414 | 0.059 | 0.233 | 18.284 | 8.445 | 19.858 | 26.494 | 18.4 | 48.3 | 69.4 | 4.4 | 39.3 | 6.2 |
| Net Income
| 52.154 | -5.219 | 57.138 | -2.985 | 629.302 | 143.321 | 12.556 | -1.636 | 257.305 | 12.024 | 11.421 | -0.527 | 10.176 | -12.515 | -1.948 | -98.114 | 281.688 | -31.743 | -36.399 | -45.141 | -37.462 | -32.596 | -42.995 | -72.376 | -74.7 | -117.9 | -100.2 | -37.3 | -64.2 | -27.1 |
| Net Income Ratio
| 0.397 | -0.027 | 0.206 | -0.016 | 5.232 | 0.57 | 0.089 | -0.015 | 3.578 | 0.186 | 0.233 | -0.017 | 0.339 | -0.532 | -0.05 | -3.592 | 21.846 | -0.225 | -0.206 | -0.276 | -0.265 | -0.337 | -0.563 | -1.504 | -1.826 | -6.661 | -1.938 | -1.014 | -2.62 | -2.038 |
| EPS
| 3.02 | -0.31 | 3.44 | -0.18 | 33.13 | 5.96 | 0.6 | -0.079 | 13 | 0.59 | 0.56 | -0.028 | 0.52 | -0.64 | -0.1 | -6.16 | 17.22 | -2.36 | -2.95 | -3.68 | -3.18 | -2.83 | -4.34 | -7.8 | -9.51 | -17.51 | -18.15 | -7.78 | -17.19 | -9.42 |
| EPS Diluted
| 2.94 | -0.31 | 3.31 | -0.18 | 31.85 | 5.96 | 0.53 | -0.079 | 12.12 | 0.56 | 0.55 | -0.027 | 0.52 | -0.64 | -0.1 | -6.16 | 17.22 | -2.36 | -2.95 | -3.68 | -3.18 | -2.83 | -4.34 | -7.8 | -9.51 | -17.51 | -18.15 | -7.78 | -17.19 | -9.42 |
| EBITDA
| 51.223 | 8.734 | 117.202 | 31.992 | -804.542 | 179.519 | 82.776 | 59.926 | 6.192 | 26.929 | 20.62 | 2.854 | -1.77 | -37.697 | -31.029 | 48.01 | -58.323 | -157.003 | -18.99 | -37.636 | 1.194 | -10.443 | -8.201 | -38.084 | -43.2 | -18.9 | 40.3 | -27.2 | 12.6 | -12.9 |
| EBITDA Ratio
| 0.39 | 0.045 | 0.423 | 0.172 | -6.689 | 0.714 | 0.587 | 0.55 | 0.086 | 0.417 | 0.421 | 0.091 | -0.059 | -1.602 | -0.797 | 1.758 | -4.523 | -1.114 | -0.108 | -0.23 | 0.008 | -0.108 | -0.107 | -0.792 | -1.056 | -1.068 | 0.779 | -0.739 | 0.514 | -0.97 |